Fleming, ShaunShaunFlemingCHENG-HONG TSAIMorris, RhiannonRhiannonMorrisHSIN-AN HOUWei, Andrew HAndrew HWei2023-12-192023-12-192023-12-0700064971https://pubmed.ncbi.nlm.nih.gov/37647854/https://scholars.lib.ntu.edu.tw/handle/123456789/637990This study reports the following: (1) frequency of TP53 comutation within each component of the European LeukemiaNet 2022 acute myeloid leukemia risk classification, (2) relevance of TP53 mutated variant allelic fraction <10%, (3) prognostic impact of -7, -5/del(5q), -17/abn(17p), complex karyotype/monosomal karyotype, or myelodysplasia-related gene mutations with/without mutated TP53.enTP53 status and impact on AML prognosis within the ELN 2022 risk classificationjournal article10.1182/blood.2023020855376478542-s2.0-85172408610